Showing results (121-130 of 253) with videos related to
Sort By:
Pageof 26
JCO Global Oncology|March 8, 2023
Clinicopathologic Features of Breast Cancer in Egypt-Contemporary Profile and Future Needs: A Systematic Review and Meta-AnalysisHamdy A Azim, Hagar Elghazawy, Ramy M Ghazy, et al.Journal of Chemotherapy (Florence, Italy)|May 20, 2024
Combination of metronomic capecitabine and letrozole in metastatic hormone receptor positive, HER2 negative breast cancer: a randomized phase II trialHamdy A Azim, Mariam A Saleh, Passant Essam Eldin, et al.International Endodontic Journal|September 11, 2020
Clinical endodontic management during the COVID-19 pandemic: a literature review and clinical recommendationsA A Azim, J Shabbir, Z Khurshid, et al.Journal of Endodontics|September 20, 2020
Pulp/Dentin Regeneration: It Should Be ComplicatedGeorge T-J Huang, Jie Liu, Xiaofei Zhu, et al.Journal of Clinical and Experimental Dentistry|January 24, 2014
Evaluation of horizontal ridge augmentation using beta tricalcium phosphate and demineralized bone matrix: A comparative studyMahmoud A Shalash, Hatem A Rahman, Amr A Azim, et al.European Journal of Cancer (Oxford, England : 1990)|June 14, 2015
Pregnancy following breast cancer using assisted reproduction and its effect on long-term outcomeOranite Goldrat, Niels Kroman, Fedro A Peccatori, et al.Tropical Doctor|October 1, 1994
Detection of Helicobacter pylori in endoscopic biopsies in SudanY A Azim Mirghani, S Ahmed, M Ahmed, et al.Arab Journal of Gastroenterology : the Official Publication of the Pan-Arab Association of Gastroenterology|November 4, 2015
Reporting of the circumferential tumour margin involvement and preoperative levels of carcinoembryonic antigen as prognostic risk factors in colorectal cancer patientsMohamed Yehia Elbarmelgi, Ahmed Farag, Hamdy A Azim, et al.Translational Oncology|April 17, 2016
Analysis of PI3K/mTOR Pathway Biomarkers and Their Prognostic Value in Women with Hormone Receptor-Positive, HER2-Negative Early Breast CancerHamdy A Azim, Loay Kassem, Isabelle Treilleux, et al.Breast (Edinburgh, Scotland)|October 22, 2011
Beyond trastuzumab: new treatment options for HER2-positive breast cancerKamal S Saini, Hatem A Azim, Otto Metzger-Filho, et al.Pageof 26